Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Efflux MexAB-Mediated Resistance in Multidrug and Pan-Drug Resistant Strains of Pseudomonas aeruginosa Isolated From Patients With Burn and Wound Infections

Azar Dokht Khosravi 1 , 2 and Ali Mohammadian 3 , *
Authors Information
1 Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Arvand International Division, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2016, 11 (1); e25352
  • Published Online: January 1, 2016
  • Article Type: Research Article
  • Received: November 15, 2014
  • Revised: January 6, 2015
  • Accepted: May 9, 2015
  • DOI: 10.17795/jjnpp-25352

To Cite: Khosravi A D, Mohammadian A. Efflux MexAB-Mediated Resistance in Multidrug and Pan-Drug Resistant Strains of Pseudomonas aeruginosa Isolated From Patients With Burn and Wound Infections, Jundishapur J Nat Pharm Prod. 2016 ; 11(1):e25352. doi: 10.17795/jjnpp-25352.

Abstract
Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daures JP, et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect. 2004; 57(3): 209-16[DOI][PubMed]
  • 2. Jung R, Fish DN, Obritsch MD, MacLaren R. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect. 2004; 57(2): 105-11[DOI][PubMed]
  • 3. Tsutsui A, Suzuki S, Yamane K, Matsui M, Konda T, Marui E, et al. Genotypes and infection sites in an outbreak of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect. 2011; 78(4): 317-22[DOI][PubMed]
  • 4. Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis. 2005; 5: 24[DOI][PubMed]
  • 5. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2006; 55: 1619-29[DOI][PubMed]
  • 6. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: an update. Drugs. 2009; 69(12): 1555-623[DOI][PubMed]
  • 7. Zechini B, Versace I. Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat Antiinfect Drug Discov. 2009; 4(1): 37-50[PubMed]
  • 8. Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plesiat P. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother. 2004; 48(5): 1797-802[PubMed]
  • 9. Yoneyama H, Maseda H, Kamiguchi H, Nakae T. Function of the membrane fusion protein, MexA, of the MexA, B-OprM efflux pump in Pseudomonas aeruginosa without an anchoring membrane. J Biol Chem. 2000; 275(7): 4628-34[PubMed]
  • 10. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res. 2003; 2(1): 48-62[PubMed]
  • 11. Forbes BA, Sahm DF, Weissfeld AS. Diagnostic microbiology. 2005;
  • 12. Clinical and Laboratory Standards Institute. . Performance Standards for Antimicrobial Susceptibility Testing; 21th Informational Supplement. Wayne;. 2012;
  • 13. Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, et al. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother. 2005; 56(1): 122-7[DOI][PubMed]
  • 14. Xavier DE, Picao RC, Girardello R, Fehlberg LC, Gales AC. Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil. BMC Microbiol. 2010; 10: 217[DOI][PubMed]
  • 15. Thong KL, Lai KS, Ganeswrie R, Puthucheary SD. Pulsed-field gel electrophoresis of multidrug-resistant and -sensitive strains of Pseudomonas aeruginosa from a Malaysian hospital. Jpn J Infect Dis. 2004; 57(5): 206-9[PubMed]
  • 16. Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med. 2007; 39(3): 162-76[DOI][PubMed]
  • 17. Pellegrino FL, Teixeira LM, Carvalho Md Mda G, Aranha Nouer S, Pinto De Oliveira M, Mello Sampaio JL, et al. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J Clin Microbiol. 2002; 40(7): 2420-4[PubMed]
  • 18. Deplano A, Denis O, Poirel L, Hocquet D, Nonhoff C, Byl B, et al. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol. 2005; 43(3): 1198-204[DOI][PubMed]
  • 19. Rastegar Lari AR, Alaghehbandan R, Akhlaghi L. Burn wound infections and antimicrobial resistance in tehran, iran: an increasing problem. Ann Burns Fire Disasters. 2005; 18(2): 68-73[PubMed]
  • 20. Bayani M, Siadati S, Rajabnia R, Taher AA. Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran. Int J Mol Cell Med. 2013; 2(4): 204-9[PubMed]
  • 21. Khosravi AD, Mihani F. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Diagn Microbiol Infect Dis. 2008; 60(1): 125-8[DOI][PubMed]
  • 22. Nikaido H, Pages JM. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev. 2012; 36(2): 340-63[DOI][PubMed]
  • 23. Fuste E, Lopez-Jimenez L, Segura C, Gainza E, Vinuesa T, Vinas M. Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa. J Med Microbiol. 2013; 62: 1317-25[DOI][PubMed]
  • 24. Yi MY, Wang PY, Huang HJ, Liu YC. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa]. Zhonghua Yi Xue Za Zhi. 2006; 86(7): 457-62[PubMed]
  • 25. Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-beta-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents. 2012; 40(2): 168-72[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments